Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
0.8726
-0.0174 (-1.96%)
Jan 16, 2026, 4:00 PM EST - Market closed
Kairos Pharma Market Cap
Kairos Pharma has a market cap or net worth of $18.17 million as of January 16, 2026. Its market cap has decreased by -6.96% in one year.
Market Cap
18.17M
Enterprise Value
12.59M
1-Year Change
-6.96%
Ranking
Category
Stock Price
$0.87
Market Cap Chart
Since the IPO on September 16, 2024, Kairos Pharma's market cap has decreased from $33.39M to $18.17M, a decrease of -45.58%. That is a compound annual growth rate of -36.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 18.17M | 22.90% |
| Dec 31, 2025 | 14.78M | -24.29% |
| Dec 31, 2024 | 19.53M | -41.52% |
| Sep 16, 2024 | 33.39M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |